Patents by Inventor Su-Young Choi

Su-Young Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10792371
    Abstract: Provided is a conjugate including a c-Met targeting compound and a bioactive material and methods of use of the conjugate.
    Type: Grant
    Filed: January 31, 2018
    Date of Patent: October 6, 2020
    Assignee: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Su Young Chae, Sunghyun Kim, Eun Ko, Yun Ju Jeong, Jae Hyun Choi
  • Publication number: 20200310185
    Abstract: A transmittance-variable layer and a transmittance-variable device including the same are disclosed herein. In some embodiments, a transmittance-variable device includes a polarization layer and a transmittance-variable layer disposed on the polarization layer, wherein the transmittance-variable layer includes a first base layer disposed on the polarization layer and a spacer fixed on a surface of the first base layer opposite to the polarization layer, and a second base layer facing the first base layer and spaced apart from the first base layer by the first spacer, wherein the first spacer maintains a gap between the first and second base layers, and a first light modulating material disposed in the gap.
    Type: Application
    Filed: November 28, 2018
    Publication date: October 1, 2020
    Applicant: LG Chem, Ltd.
    Inventors: Jung Woon Kim, Su Young Ryu, Byoung Kun Jeon, Yong Sung Choi, Seong Min Lee, Hye Min Yu
  • Publication number: 20200297865
    Abstract: In some aspects, the invention relates to an antibody-drug conjugate, comprising an antibody; a linker; and an active agent. The antibody-drug conjugate may comprise a self-immolative group. The linker may comprise an O-substituted oxime, e.g., wherein the oxygen atom of the oxime is substituted with a group that covalently links the oxime to the active agent; and the carbon atom of the oxime is substituted with a group that covalently links the oxime to the antibody.
    Type: Application
    Filed: November 23, 2016
    Publication date: September 24, 2020
    Inventors: Yong Zu Kim, Yeong Soo Oh, Jeiwook Chae, Ho Young Song, Chul-Woong Chung, Yun Hee Park, Hyo Jung Choi, Kyung Eun Park, Hyoungrae Kim, Jinyeong Kim, Ji Young Min, Sung Min Kim, Byung Soo Lee, Dong Hyun Woo, Ji Eun Jung, Su In Lee
  • Patent number: 10767078
    Abstract: Embodiments relate to a water soluble paint composition for a vehicle. The water soluble paint composition includes a core-shell microgel resin, a dimer-modified polyester resin, a (meth)acryl-modified polyurethane resin, a curing agent, a pigment, and water, wherein the dimer-modified polyester resin is included in an amount of 1 to 10 wt % with respect to 100 wt % of the water-soluble paint composition. When the water soluble paint composition according to various embodiments is used to paint a vehicle, air handling equipment and an oven are not needed, so that energy can be saved in the painting process, CO2 production can be reduced, costs can be saved for painting equipment and maintenance, and space for a painting line can be saved, and a paint layer can be formed having excellent smoothing, waterproofing, chipping resistance, and outer appearance.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: September 8, 2020
    Assignee: KCC Corporation
    Inventors: Su Young Cho, Yong Joo Kim, Seung Min Hong, So Jin Kang, Yong Ho Choi, Bon Yi Lee
  • Patent number: 10766933
    Abstract: The present invention relates to a mutated immunoglobulin-binding protein having increased alkaline tolerance and, more specifically, to an immunoglobulin-binding protein in which, with respect to the A-domain of Staphylococcal protein A, or a functional variant thereof, an amino acid at a specific site is mutated and thereby exhibits an increased chemical stability at an alkaline pH value in comparison to a parental molecule. The present invention can provide an antibody-purifying immunoglobulin-binding protein ligand and matrix which have enhanced alkaline tolerance and accordingly enhanced stability in multiple times of alkaline cleaning.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: September 8, 2020
    Assignee: Amicogen, Inc.
    Inventors: Yong Chul Shin, Zhe Piao, Su-Lim Choi, Yang Ho Jo, So-Young Park, Dae Beom Kwon
  • Patent number: 10770026
    Abstract: Disclosed are a display device, and a source driver and a packet recognition method thereof. In the display device, when check information of a control data packet of transmitted transmission data is normal, a control data packet of to be restored is updated with a control data packet of a current cycle, and when the check information is abnormal, the control data packet to be restored is maintained, so that it is possible to normally drive a source signal even through there is an error or a change in the control data packet.
    Type: Grant
    Filed: December 12, 2017
    Date of Patent: September 8, 2020
    Assignee: Silicon Works Co., Ltd.
    Inventors: Ju Young Shin, Sang Min Lee, Su Hun Yang, Jeung Hie Choi
  • Patent number: 10772131
    Abstract: An apparatus implements methods for random access in a wireless communication system using beamforming. A Subscriber Station (SS) measures a best downlink transmission beam among downlink transmission beams transmitted from a Base Station (BS), and transmits Random Access Channel (RACH) information, which includes indication information indicating the best downlink transmission beam, to the BS. The BS receives RACH information which includes indication information indicating a best downlink transmission beam among downlink transmission beams, and detects an RACH sequence and the best downlink transmission beam from the received RACH information.
    Type: Grant
    Filed: August 31, 2018
    Date of Patent: September 8, 2020
    Assignee: Samsung Electronics Co., Ltd.
    Inventors: Hyun-Kyu Yu, Tae-Young Kim, Jeong-Ho Park, Su-Ryong Jeong, Joon-Young Choi
  • Patent number: 10730984
    Abstract: The present invention relates to a modifier represented by Formula 1, a modified conjugated diene-based polymer having a high modification ratio which includes a modifier-derived functional group, and a method of preparing the polymer.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: August 4, 2020
    Assignee: LG Chem, Ltd.
    Inventors: Su Hwa Kim, Hyo Jin Bae, Jeong Heon Ahn, Sung Ho Park, Soo Young Choi, Dong Hui Kim
  • Patent number: 10722548
    Abstract: The present invention relates to a method of preparing a lyophilizate of a Taheebo alcohol extract, including: (a) extracting Taheebo with an alcohol and concentrating an extract; and (b) lyophilizing the alcohol-extracted and concentrated Taheebo, and a composition for the treatment, prevention or amelioration of an inflammatory disease including a lyophilizate of a Taheebo alcohol extract prepared therefrom.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: July 28, 2020
    Assignees: COSMAX NBT, INC., COSMAX NS, INC.
    Inventors: Kwang Soo Baek, Jin Hak Kim, Su Young Choi, Young Min Park, Jae Seok Shim, Sang Woo Kim, Mann Seok Yoon, Yoon Jong Lee
  • Publication number: 20200223969
    Abstract: A modified conjugated diene-based polymer, and more particularly, a modified conjugated diene-based polymer having a unimodal molecular weight distribution curve measured by gel permeation chromatography (GPC), molecular weight distribution (PDI; MWD) of less than 1.7, and a Si content of 100 ppm or more based on weight, and including a repeating unit derived from an aromatic vinyl monomer in an amount from 15 wt % to less than 30 wt %, and a rubber composition including the same.
    Type: Application
    Filed: December 8, 2017
    Publication date: July 16, 2020
    Applicant: LG Chem, Ltd.
    Inventors: Ro Mi Lee, No Ma Kim, Yu Jin Kim, Ho Young Lee, Sun Keun Kim, Su Min Na, Youk Reol Na, Heung Yeal Choi
  • Publication number: 20200223938
    Abstract: The present invention relates to a polypeptide including an Fc variant produced by substituting a portion of the amino acid sequence of the Fc domain of a human antibody with a different amino acid sequence. The present invention also relates to an antibody including the polypeptide. The Fc variant can find application in a wide range of antibodies and Fc-fusion constructs. In one aspect, the antibody or Fc fusion construct of the present invention is a therapeutic, diagnostic or laboratory reagent, preferably a therapeutic reagent. The Fc variant is suitable for use in the treatment of cancer because its in vivo half-life can be maximized by optimization of the portion of the amino acid sequence. The antibody or Fc fusion construct of the present invention is used to kill target cells that bear a target antigen, for example cancer cells. Alternatively, the antibody or Fc fusion construct of the present invention is used to block, antagonize or agonize a target antigen.
    Type: Application
    Filed: April 6, 2018
    Publication date: July 16, 2020
    Applicants: KOOKMIN UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION, OSONG MEDICAL INNOVATION FOUNDATION
    Inventors: Sang Taek JUNG, Sanghwan KO, Tae Gyu LEE, So Young CHOI, Soo Han LEE, Myung Ho SOHN, Su Jin KIM, So Ra PARK, Jong Shik PARK, Ju Hyeon LIM
  • Publication number: 20200215455
    Abstract: The present invention relates to a micro device for solid phase extraction and more particularly provides a micro device which is configured to perform solid phase extraction by injecting a filler and a solvent and producing a uniform flow of the solvent.
    Type: Application
    Filed: October 12, 2018
    Publication date: July 9, 2020
    Applicant: LG Chem, Ltd.
    Inventors: Seonyoung Jegal, Dae Hun Kim, Byoung Hyoun Kim, Yeu Young Youn, Kyoungjoo Jin, Jun Won Choi, Su Youn Han
  • Publication number: 20200216724
    Abstract: An adhesive composition and an adhesive film are provided.
    Type: Application
    Filed: September 28, 2018
    Publication date: July 9, 2020
    Applicant: LG Chem, Ltd.
    Inventors: Su Eun Lee, Joo Hyun Lee, Hu Young Yoon, Jun Man Choi, Jang Soon Kim, Kwang Su Seo
  • Publication number: 20200189464
    Abstract: The apparatus for controlling a display mirror for a vehicle includes an operation mode determiner for determining an operation mode based on a position of a mirror assembly, the mirror assembly accommodating a display for displaying an image obtained by an imaging device within an inner space formed by a mirror coupled to a surface of a mirror housing; a power supply for supplying a power to the display; and a controller configured to adjust an intensity of the power supplied to the display based on the determined operation mode. The operation mode determiner determines between a first operation mode in which an image reflected by the mirror is visible to a driver and a second operation mode in which the image obtained by the imaging device is displayed on the display. In particular, the display remains turned on in the first operation mode and the second operation mode.
    Type: Application
    Filed: November 15, 2019
    Publication date: June 18, 2020
    Inventors: Minhee LEE, Su Young CHOI, Jinhwan MOON, Seokkeon KWON, Changju KIM, Jung Yeol YE
  • Publication number: 20200179686
    Abstract: Provided is a respiratory muscle strengthening device, in which an inhalation start signal is generated correspondingly at an inhalation start time when a patient inhales air or an exhalation start signal is generated correspondingly at an exhalation start time when the patient exhales air, an electric signal according to the inhalation start signal or the exhalation start signal is transmitted to an electric muscle stimulator via a communication unit, a muscle pad installed on respiratory muscles of the patient enables smooth breathing motion by stimulating the respiratory muscles based on a signal transmitted from the electric muscle stimulator, and a receptor pad is provided to the respiratory muscles such that an alarm of determining whether electric stimulation is normally applied via the state of the respiratory muscles detected through the receptor pad is output, thereby securing reliability of a device.
    Type: Application
    Filed: June 20, 2017
    Publication date: June 11, 2020
    Applicant: RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY
    Inventors: Su Min SON, Eun Yong CHOI, Joon Ha LEE, So Young KWAK
  • Patent number: 10679090
    Abstract: A method for estimating 6-DOF relative displacement using vision-based localization and apparatus therefor are disclosed. A method for estimating 6-DOF relative displacement may include acquiring images of a first marker attached to a fixing member and a second marker attached to a dynamic member for assembling to the fixing member by using a camera, extracting a feature point of the first marker and a feature point of the second marker through image processing for the acquired images, and estimating 6-DOF relative displacement of the dynamic member for the fixing member based on the extracted feature point of the first marker and feature point of the second marker.
    Type: Grant
    Filed: May 14, 2018
    Date of Patent: June 9, 2020
    Assignee: KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
    Inventors: Hyeon Myeong, Su Young Choi, Wancheol Myeong
  • Patent number: 10632920
    Abstract: A rearview mirror having a tilting structure configured for securing a rear view through a display device by tilting an upper housing may include: a lower housing configured to be fixed to a windshield glass; an upper housing configured to be positioned at an opening portion of the lower housing; a mirror portion configured to be positioned at a rear surface of the upper housing; and a display device configured to be positioned at a rear surface of the mirror portion, in which the mirror portion and the display device are fixed to the upper housing, and the upper housing is tilted based on a first end portion to provide a rear view through the display device.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: April 28, 2020
    Assignees: Hyundai Motor Company, Kia Motors Corporation
    Inventors: Nak Kyoung Kong, Jong Min Park, Ki Hong Lee, Keun Sig Lim, Chang Ju Kim, Yong Hwan Kim, Su Young Choi, Won Bin Kim
  • Publication number: 20200124598
    Abstract: A diagnostic cartridge includes a chip, in which a channel connecting an inlet and an outlet of the liquid is formed, a biosensor adjacent to the channel, and a circuit for supplying power to the biosensor, and when the target material binds to the biosensor, the resistance of the biosensor may be changed.
    Type: Application
    Filed: December 20, 2018
    Publication date: April 23, 2020
    Applicants: NDD, INC., GUMI ELECTRONICS & INFORMATION TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Hyung Jin KIM, Su Han LEE, Min Ji CHOI, Sae Young AHN, Hyun Hwa KWON, Sang Keun SUNG
  • Publication number: 20200111444
    Abstract: Disclosed are a display device, and a source driver and a packet recognition method thereof. In the display device, when check information of a control data packet of transmitted transmission data is normal, a control data packet of to be restored is updated with a control data packet of a current cycle, and when the check information is abnormal, the control data packet to be restored is maintained, so that it is possible to normally drive a source signal even through there is an error or a change in the control data packet.
    Type: Application
    Filed: December 12, 2017
    Publication date: April 9, 2020
    Applicant: SILICON WORKS CO., LTD.
    Inventors: Ju Young SHIN, Sang Min LEE, Su Hun YANG, Jeung Hie CHOI
  • Patent number: 10611797
    Abstract: A peptide binding to transcription factor CP2c, having an activity of preventing and treating cancer and represented by SEQ ID NO: 1: Asn-Tyr-Pro-Gln-Arg-Pro, and a pharmaceutical composition and a dietary supplement composition for preventing and treating cancer, both of which contain the same as an active ingredient are disclosed. When cancer cells are treated with the peptide and the pharmaceutical composition containing the same, the peptide can specifically bind to CP2c by passing, with very high stability, through the cell membrane and can inhibit the DNA binding ability of CP2c, thereby disturbing CP2c-mediated cancer cell-specific transcriptional activity through the inhibition of CP2c activity. Thus, the peptide and pharmaceutical composition containing the same can be effectively used for specifically treating only cancer cells and can be utilized for cancer prevention and as a dietary supplement additive therefor.
    Type: Grant
    Filed: March 29, 2016
    Date of Patent: April 7, 2020
    Assignee: IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY)
    Inventors: Chul Geun Kim, Min Young Kim, Chan Gil Kim, Ho Chul Kang, Ji Hyung Chae, Su Jae Lee, Eun Jung Baek, Chae Ok Yun, Jin Won Lee, Young Su Lim, Je Min Choi, Dae Hyun Ha, Hyung Sik Won, Seung Han Son